Journal of Pharmacy Practice and Research最新文献

{"title":"Antimicrobial-impregnated bone cement use in Australian hospitals: scoping pharmacist awareness and involvement in management","authors":"Alice Pei Kheng Teoh MPharm, MPH,&nbsp;Nadine Hillock BPharm, DipClinPharm, MPH","doi":"10.1002/jppr.1846","DOIUrl":"10.1002/jppr.1846","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Antibiotic-impregnated bone cement (AIBC) is frequently used in arthroplasty surgery to minimise the risk of infection in the prosthetic knee or hip joint.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To gain greater insight into the use, documentation, and stock-management of AIBC in Australian hospitals.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>A mixed-methods study was conducted. Antimicrobial surveillance data were analysed to identify Australian hospitals including AIBC in their monthly pharmacy data submissions. An online survey was distributed to pharmacists registered with the National Antimicrobial Utilisation Surveillance Program to investigate knowledge of the use, documentation, and stock-management of bone cement.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Surveillance data from January to June 2021 showed 13% (<i>n</i> = 28) of the 222 participating hospitals included bone cement in their antimicrobial usage data. All reported AIBC usage data contained an aminoglycoside antibiotic. Fifty-two pharmacists responded (17% response rate) to the online survey. When asked about inventory, 35% of participants stated that their hospital pharmacies manage bone cements. Of 82 responses, 6% (<i>n</i> = 5) had knowledge of additional antibiotics or antifungals loaded into bone cements intraoperatively. More than half of the respondents reported that documentation of AIBC use was unclear, while others knew to search for it in prosthesis or theatre notes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This study has illustrated a gap in pharmacists' knowledge in the perioperative setting regarding the use and documentation of bone cement, and highlights a possible focus for future education to assist with antimicrobial stewardship in this setting. Consistency in the management and documentation of AIBC would assist in surveillance of usage, help identify variations in practice and provide opportunities for quality improvement.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 2","pages":"73-78"},"PeriodicalIF":2.1,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48111836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating pharmacy high-needs criteria: a tool for identifying inpatients at risk of medication-related problems","authors":"Paul Wembridge,&nbsp;Cathy Ngo,&nbsp;Thi Huong Tra Tran,&nbsp;Maanya Pavan Ivar","doi":"10.1002/jppr.1845","DOIUrl":"10.1002/jppr.1845","url":null,"abstract":"<p>Clinical pharmacy services can be costly, and in resource-constrained healthcare services, should be prioritised towards patients with the greatest potential risks. At our health network, high-needs pharmacy criteria were developed to identify patients at greatest need of clinical pharmacy services. This retrospective study of 761 patients admitted to four hospitals in metropolitan Melbourne aimed to evaluate the ability of the high-needs pharmacy criteria to identify patients at increased risk of medication-related adverse clinical outcomes. Patients' clinical records were reviewed to determine if the patient met one or more elements of the high-needs criteria. Data on length of stay, 30-day readmission rate, medication-related problems, and medication-related incidents were obtained from the electronic records. Patients meeting one or more high-needs criteria had a longer length of stay (mean 6.7 days vs 3.1 days, p &lt; 0.01), were more likely to be readmitted within 30 days (27% vs 16%, p &lt; 0.01) and had a higher rate of medication-related problems (15% vs 7.6%, p &lt; 0.01). The sensitivity of the high-needs criteria to identify patients with medication-related problems, medication-related incidents, or readmission within 30 days was above 80%. In conclusion, the high-needs pharmacy criteria identified older patients with longer length of stay who are at greater risk of 30-day readmission and medication-related problems.</p>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 2","pages":"91-95"},"PeriodicalIF":2.1,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1845","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45083195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacy Forecast Australia 2022: partner perspective — Climate and Health Alliance","authors":"Stefanie Carino PhD, BND (Hons),&nbsp;Roland Sapsford BA (Hons) (1st),&nbsp;Fiona Armstrong BN, GradDipJoun, MPPP","doi":"10.1002/jppr.1848","DOIUrl":"10.1002/jppr.1848","url":null,"abstract":"&lt;p&gt;Environmental sustainability is a key issue associated with pharmaceutical use in Australia. The pharmaceutical sector contributes to climate change by producing substantial greenhouse gas emissions and large amounts of waste.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; Pharmaceutical pollution is a well-established threat to ecosystems, with harmful effects on animal and plant life, and human health. Pharmaceuticals can enter the environment at all stages of their life cycle, through manufacturing, patient excretion, and incorrect disposal.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Global Green and Healthy Hospitals (GGHH) is an international network of hospitals, healthcare facilities, health systems, and health organisations dedicated to reducing their environmental footprint and promoting public and environmental health.&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt; To achieve this goal, GGHH has a comprehensive Sustainability Agenda consisting of a 10-goal framework. The safe management and disposal of pharmaceuticals is one area of the framework.&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt; The Climate and Health Alliance promotes GGHH's Sustainability Agenda in Australia and New Zealand, and coordinates the GGHH Pacific Region network.&lt;/p&gt;&lt;p&gt;Through the GGHH network, we are exposed to individuals working in the health sector who are leading and driving sustainable healthcare practices, including in pharmacy. In Australia to date, this work has largely focused on auditing and reducing pharmaceutical waste, as well as its safe disposal. All hospitals need to embed regular pharmaceutical waste audits into ongoing practice, consider current procurement and disposal practices, and develop policies to support quality use and prevent overuse. Health professionals can play a key role in minimising the effects of pharmaceuticals on the environment by optimising prescription practices, educating patients (e.g. around best use of medicines and effective antibiotic use), and advising patients on the appropriate disposal of medicines.&lt;/p&gt;&lt;p&gt;Professional bodies have a crucial role in providing specific guidance and practical advice in relation to environmental sustainability and climate change. &lt;i&gt;Pharmacy Forecast Australia 2022&lt;/i&gt;, prepared by the Society of Hospital Pharmacists of Australia, captured the perspectives of experts in health system pharmacy to develop strategic recommendations for environmental sustainability and pharmacy.&lt;span&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt; Recommendations relating to clinical practice include clinicians' pharmaceutical choices accounting for environmental impact, working towards paper-free pharmacy departments, monitoring wastage data, establishing pharmaceutical waste programs, and considering the environment within pharmacy procurement. The Forecast also addresses the capacity of the current and future workforce, with recommendations to embed environmental sustainability into the pharmacy curriculum, and to support environmental sustainability champions.&lt;/p&gt;&lt;p&gt;Such recommendations are an impor","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"52 6","pages":"409-410"},"PeriodicalIF":2.1,"publicationDate":"2022-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1848","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43071610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Older people, medication safety, and the role of the community pharmacist: a longitudinal ethnographic study","authors":"Aileen Collier RN, PhD,&nbsp;Deborah Balmer MA, PhD,&nbsp;Linda Dai BPharm, MPS,&nbsp;Joanna Hikaka BPharm, PhD,&nbsp;Katherine Bloomfield MBChB, FRACP,&nbsp;Michal Boyd NP, ND","doi":"10.1002/jppr.1839","DOIUrl":"10.1002/jppr.1839","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Older people with frailty and multimorbidity are at high risk of problematic polypharmacy. Community pharmacists have a key role in medication safety for older people.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>The aim of this study was to investigate the perspectives of older people with frailty, multimorbidity, and polypharmacy, and their family caregivers or <i>whānau</i> on the role of community pharmacists, including <i>in situ</i> pharmacist care practices.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>This study was part of a larger video reflexive ethnography (VRE) study to explore medication safety and wellbeing for older people with frailty across care transitions including hospital, home, aged residential care, primary care, and outpatient care. This paper reports data from the interview, participant observation, and filming phases of the study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Community pharmacists play a significant role in the medication safety of older people with frailty and polypharmacy. Analysis resulted in three main themes: (1) the older person–determined role of the pharmacist, (2) the ‘taken for granted’ safety work of the pharmacist, and (3) collective agency and medication safety.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>In circumstances where older people and their family caregivers or <i>whānau</i> had a trusted relationship with a community pharmacist, the pharmacist played a key role as mediator of medication safety and was central to older people's care. This key role as a member of the multidisciplinary team in the care of older people with frailty and multimorbidity should be better recognised and legitimised by clinicians and policy makers and resourced accordingly.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 1","pages":"18-25"},"PeriodicalIF":2.1,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1839","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43663981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Psychotropic medicines are frequently dosed outside recommended ranges: a clinical audit in an Australian mental health hospital","authors":"Ghadir Soliman MClinPharm, MSc, BPharm,&nbsp;Adam LaCaze PhD, GDipClinPharm, BPharm","doi":"10.1002/jppr.1840","DOIUrl":"10.1002/jppr.1840","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Compliance with psychotropic dosage guidelines has been shown to improve mental health status, reduce severity of symptoms, and decrease adverse effects. However, guideline recommendations are not always implemented. While deviation from dosage recommendations may be clinically appropriate in some patients, variation can cause a lack of efficacy or patient harm.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To evaluate the incidence of antidepressant and antipsychotic prescribing at doses outside the recommended range provided by local guidelines, <i>Therapeutic</i> <i>Guidelines</i><i>:</i> <i>Psychotropic</i>.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>This study is a retrospective clinical audit of 793 patients admitted to hospital between August 2018 and July 2019. Data were collected through extensive file and chart reviews of patients treated with any of the antidepressant and antipsychotic medications listed in the <i>Psychotropic Dosage Guidelines</i>. Descriptive statistical analyses were performed to determine frequencies and proportions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The audit identified that 38.0% of patients received doses of antidepressants or antipsychotics outside the recommended range. Most antidepressants were prescribed within recommended doses (83.0%), with 10.5% above the recommended dose, and 6.2% below. Fewer antipsychotics were prescribed within the recommended range (56.8%), 2.8% were prescribed at doses above the recommended range, and 40.3% were prescribed at doses below the recommendation range. Quetiapine was frequently prescribed at doses lower than recommended.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The audit revealed a substantial amount of prescribing outside the recommended dosage ranges. It also highlighted the necessity of reviewing policies to limit the use of off-label, low-dose quetiapine. Audit and feedback could target psychiatrists who seem to have the highest propensity to prescribe outside the recommended dosage ranges.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 1","pages":"1-9"},"PeriodicalIF":2.1,"publicationDate":"2022-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44863716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expansion of the partnered pharmacist medication charting model on admission in the General Medicine Unit — initiation of new medications","authors":"Phuong U. Hua BPharm(Hons),&nbsp;Gail Edwards BPharm, MClinPharm,&nbsp;Eleanor Van Dyk BPharm, MClinPharm,&nbsp;Gary Yip MBBS, FRACP,&nbsp;Biswadev Mitra MBBS, MHSM, PhD, FACEM,&nbsp;Michael J. Dooley BPharm, GradDipHospPharm, PhD, FISOPP, FSHPA, FAAQHC,&nbsp;Erica Y. Tong BPharm(Hons), MClinPharm, PhD","doi":"10.1002/jppr.1842","DOIUrl":"10.1002/jppr.1842","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Increasing life expectancy has seen a continual rise in older patients who present to hospital with acute decompensation. Pharmacists are well equipped to make medication recommendations in these settings to meet patient care needs, promote harm minimisation, and improve workflow efficiency. The Partnered Pharmacist Medication Charting (PPMC) model enables pharmacists to chart regular medications for patients admitted to the General Medicine Unit (GMU) in collaboration with treating clinicians. The model was expanded to assess the safety of pharmacists additionally charting newly initiated medications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>The aim of this study was to assess the safety of the expanded PPMC model through the number of medication errors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>This prospective observational study was conducted at a tertiary hospital. Patients admitted to the GMU and received PPMC were included. Pharmacists were able to chart any new medications as well as the patients' pre-admission medications. The primary outcome was the number of medication errors charted on admission. Medication errors were defined as medications charted outside of the specific recommendations documented in the medication management plan written by the PPMC pharmacist and co-signed by the admitting medical officer.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 8093 medications were charted by a credentialed pharmacist, with 10% (<i>n</i> = 816) planned newly initiated medications. Eight (0.98%) medication charting errors were identified in the PPMC model, which included five planned medications omitted. Of the 811 newly charted medications, 87 (10.7%) were amended within 24 h, with the majority being due to change in diagnosis or driven by changes in clinical status or investigative results becoming available.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The expansion of the PPMC model of care to enable pharmacist charting of new medications was found to be safe. The adoption of the model may aid in reducing medication errors, thereby improving patient care and safety.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 1","pages":"26-31"},"PeriodicalIF":2.1,"publicationDate":"2022-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42491672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge, attitudes, and practices of Australian oncology health professionals on complementary medicines","authors":"Martin R. Keene,&nbsp;Ian M. Heslop,&nbsp;Sabe S. Sabesan,&nbsp;Beverley D. Glass","doi":"10.1002/jppr.1838","DOIUrl":"10.1002/jppr.1838","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Approximately half of people with cancer are using complementary and alternative medicine (CAM), presenting safety concerns due to potential interactions with conventional cancer treatment. Oncology staff have a role to play in ensuring the safe use of CAMs and so, this study examined their knowledge, attitudes, and practices regarding CAMs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This study aimed to assess the knowledge, attitudes, and practices of Australian doctors, nurses, and pharmacists regarding CAM use in oncology.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Members of three national oncology professional associations took part in an online questionnaire, which determined their knowledge, attitudes, and practices regarding CAM.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Ninety-nine completed surveys were obtained from nine doctors, 70 nurses, and 20 pharmacists. Most respondents (68.4%) felt that they did not have adequate knowledge of CAMs to respond to patients' questions. Assessment of attitudes found respondents generally believed that CAMs have a complementary role in oncology but indicated their concerns for the safety of patients. Respondents indicated in practice they would discuss CAMs with less than half of patients (40.6%), with a lack of scientific data and guidelines for CAM use presenting significant barriers to these discussions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our study suggests that oncology health professionals' knowledge of CAMs potentially leads to a lack of confidence in providing advice to patients and concerns for patient safety. This impacts their discussion of CAMs and lack of disclosure from patients about their use of CAMs. Education on CAMs in oncology would assist in increasing professionals' confidence in discussing these therapies, leading to increased patient disclosure of CAMs and safer treatment decision making for people with cancer.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 1","pages":"10-17"},"PeriodicalIF":2.1,"publicationDate":"2022-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1838","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42715282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Who is asking? Requests for antimicrobial prescribing advice received by hospital pharmacists","authors":"Sarah Wise LLB, MSc, PhD,&nbsp;Eloise Smith BMedSc(Hons),&nbsp;Lilibeth Carlos BPharm,&nbsp;Matthew Coleshill BSc(Hons), PhD,&nbsp;Richard Osborne Day MBBS(Hons), MD, FRACP,&nbsp;Terry Melocco BPharm,&nbsp;Jane Ellen Carland BMedSc(Hons), PhD","doi":"10.1002/jppr.1841","DOIUrl":"10.1002/jppr.1841","url":null,"abstract":"<p>Doctors are perceived as the primary decision makers in antimicrobial therapy, but prescribing decisions are influenced by the multidisciplinary team. Antimicrobial stewardship (AMS) programs formalise interprofessional advice-giving. No studies capture the advice provided by pharmacists. This study aimed to describe the volume and nature of antimicrobial prescribing advice that healthcare professionals seek from hospital pharmacists. A prospective audit of antimicrobial-related advice requests received by pharmacists (<i>n</i> = 18) at an Australian public hospital was undertaken in July 2020. Antimicrobial advice was sought from 11 pharmacists on 300 occasions. Most requests (80%) were received by the AMS pharmacist. A mean (range) of 30 (17–40) requests per day was recorded and the AMS pharmacist received 24 (16–31) requests daily. Most requests came from the intensive care unit (22.1%), pharmacy (21.4%), and infectious diseases (17.1%). The AMS pharmacist was mostly contacted by consultants and pharmacists, and other pharmacists were contacted by registrars and junior medical officers. Despite COVID-19 adaptations, face-to-face interaction was most common. This audit demonstrates the value of an AMS pharmacist, and indicates the importance of face-to-face interactions and the formalisation of pharmacists' role in prescribing decision-making. Pharmacists provided antimicrobial advice daily to other healthcare professionals. Further research is required to provide insights into the barriers and enablers to effective advice-giving interactions.</p>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 1","pages":"39-43"},"PeriodicalIF":2.1,"publicationDate":"2022-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1841","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46144542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Are our leaders and managers aware of their responsibilities in ensuring culturally safe workplaces for staff?","authors":"Susan Trevillian BPharm, PGradDipPharm, AdvPP(II), MSHP,&nbsp;Aleena Williams MPharm, BPharmSci, GradDiP PharmPrac,&nbsp;Russell Hill BPharm, PGradDipPharm (Dist), GradDipBus, MBA (Dist), FPS","doi":"10.1002/jppr.1837","DOIUrl":"10.1002/jppr.1837","url":null,"abstract":"&lt;p&gt;The &lt;i&gt;United Nations Declaration on the Rights of Indigenous Peoples&lt;/i&gt; (UNDRIP) remains the most comprehensive international instrument on the rights of First Nations peoples around the world, setting standards for survival, dignity, and wellbeing. Under the UNDRIP, the Aboriginal and Torres Strait Islander Peoples of Australia “have an equal right to the enjoyment of the highest attainable standard of physical and mental health”.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; In 2017, when the UNDRIP was first adopted by the United Nations General Assembly, Australia was one of four countries who did not vote in support. Whilst Australia and its three counterparts later reversed their positions and now support the UN declaration, this chapter in history illustrates the challenges that face those seeking to address discriminatory attitudes within the Australian community.&lt;/p&gt;&lt;p&gt;Throughout Australia, freedom from racism at work is protected by legislation, the &lt;i&gt;Fair Work Act 2009&lt;/i&gt;.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; When bias, discrimination, and racism occur in the workplace “the psychological and cultural safety of staff” is threatened, “feelings of acceptance and respect at work” are weakened, and the burnout of staff may result.&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt; It is important that leaders and managers understand the effects of structural racism on workplace dynamics, and that they identify and act on incidences of racism in the workplace.&lt;/p&gt;&lt;p&gt;This understanding is crucial, not only to fostering a workplace that is free from racism, but for ensuring all pharmacists have access to training and education to further develop their own cultural capacity, communication skills, and ability to connect with First Nations Peoples. These competencies are described within the &lt;i&gt;National Competency Standards Framework for Pharmacists in Australia&lt;/i&gt;,&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt; the Pharmacy Council of New Zealand's &lt;i&gt;Competence Standards for the Pharmacy Profession,&lt;/i&gt;&lt;span&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt; and internationally.&lt;/p&gt;&lt;p&gt;A pharmacists' development of cultural competency can be accelerated by undertaking cultural responsiveness training and focusing on developing appropriate communication skills that enable the delivery of care to First Nations Peoples in a culturally safe manner. Undergraduate pharmacy programs and pharmacy intern training programs in Australia are including these elements of pharmacy practice within their curriculums, so Australia's newly registered pharmacists are arguably the most culturally responsive we have ever had.&lt;/p&gt;&lt;p&gt;But what of their leaders and managers?&lt;/p&gt;&lt;p&gt;Successful leaders can often point to mentors who have guided elements of their career. ‘Mentors’ are defined within the Australian Competency Standards Framework as “those who share their knowledge, expertise and experience on career, technical, professional &lt;i&gt;and&lt;/i&gt; cultural issues with another individual”.&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt; Amongst those you consider your mentors, is there someone fro","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"52 5","pages":"329-331"},"PeriodicalIF":2.1,"publicationDate":"2022-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1837","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47100392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development and trial of an instrument to evaluate accredited pharmacists' clinical home medicines review reports in Australia","authors":"Marea Patounas PhD, BPharm, MPS, AACPA, SFHEA, AFHEA (Indigenous),&nbsp;Esther T. L. Lau PhD, BPharm (Hons), GCResComm, GradCertAcadPrac, SFHEA, AFHEA (Indigenous), MPS,&nbsp;Deborah Rigby BPharm, GradDipClinPharm, AdvPracPharm, FPS, FSHP, FACP, FASCP FAICD,&nbsp;Vincent Chan PhD, BPharm, MPH, MPS,&nbsp;Lisa M. Nissen PhD, BPharm, AdvPracPharm, FPS, FHKAPh, FSHP","doi":"10.1002/jppr.1829","DOIUrl":"10.1002/jppr.1829","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>In Australia, clinical reports are written by an accredited pharmacist following in-home patient consultations as part of a home medicines review (HMR). These reports communicate clinical findings and recommendations to the patient's general practitioner to optimise medicines and improve patient health. However, it is unknown if clinical HMR reports adhere to practice guidelines. This study aimed to develop an instrument from Australian practice guidelines, and then test the instrument by evaluating a small sample of clinical HMR reports written by accredited pharmacists. An instrument was developed from a consolidation of HMR practice guidelines and then applied to a small sample of de-identified clinical HMR reports provided by accredited pharmacists. The instrument developed contained 30 criteria for clinical HMR report writing, and 20 HMR reports were evaluated from 12 accredited pharmacists. Seven of the 30 criteria were met by all clinical HMR reports evaluated (were consumer-focused, documented a medicines list, medicines strengths, medicines directions, medication-related problems, and included both evidence-based and clinical recommendations for optimising medicines management). However, of the 20 HMR reports evaluated only 30% (<i>n</i> = 6) documented the general practitioner's reason for HMR referral, 60% (<i>n</i> = 12) detailed allergies/adverse drug reactions, 50% (<i>n</i> = 10) documented an adherence statement, and 20% (<i>n</i> = 4) documented vaccination status. Clinical HMR reports evaluated in this small study were aligned with practice guidelines for some criteria. Future research is warranted in a larger study to further investigate clinical HMR report writing adherence to practice guidelines in Australia.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 1","pages":"32-38"},"PeriodicalIF":2.1,"publicationDate":"2022-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1829","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42924128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}